A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 8, 2011, Pages 1599-1610

  Ishak, Miriam B ^a   Giri, Veda N ^b  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICAN AMERICAN; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOME 8Q; DATA BASE; FAMILIAL CANCER; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REPLICATION STUDY; RISK ASSESSMENT; SHORT SURVEY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS;

EID: 79961241801     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0312     Document Type: Short Survey

References (52)

1. Cancer facts and figures, 2011. Atlanta, GA: American Cancer Society; 2011.
2. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci 2006;11:1388-413. (Pubitemid 43253429)
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
4. Carter BS, Bova GS, Beaty TH, Steinberg GD, Childs B, Isaacs WB, et al. Hereditary prostate cancer: epidemiologic and clinical features. J Urol 1993;150:797-802. (Pubitemid 23241269)
5. Stanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev 2001;23:19-23. (Pubitemid 32906609)
6. Hindorff LA JH, Hall PN, Mehta JP, Manolio TA. A catalog of published genome-wide association studies 2011 [cited 2011 Feb 15]. Available from: www.genome.gov/gwastudies.
7. Stadler ZK, Vijai J, Thom P, Kirchhoff T, Hansen NA, Kauff ND, et al. Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am 2010;24:973-96.
8. Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, et al. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet 2011;43:570-3.
9. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5. (Pubitemid 40202029)
10. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 2008;40:316-21. (Pubitemid 351311772)
11. Xu J, Kibel AS, Hu JJ, Turner AR, Pruett K, Zheng SL, et al. Prostate cancer risk associated loci in African Americans. Cancer Epidemiol Biomarkers Prev 2009;18:2145-9.
12. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008;40:310-5. (Pubitemid 351311773)
13. Waters KM, Le Marchand L, Kolonel LN, Monroe KR, Stram DO, Henderson BE, et al. Generalizability of associations from prostate cancer genome-wide association studies in multiple populations. Cancer Epidemiol Biomarkers Prev 2009;18:1285-9.
14. Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, et al. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev 2011;20:23-32.
15. Gudmundsson J, Sulem P, Manolescu A, Amundadottir LT, Gudbjartsson D, Helgason A, et al. Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24. Nat Genet 2007;39:631-7. (Pubitemid 46676102)
16. Robbins C, Torres JB, Hooker S, Bonilla C, Hernandez W, Candreva A, et al. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus. Genome Res 2007;17:1717-22. (Pubitemid 351359995)
17. Wang Y, Ray AM, Johnson EK, Zuhlke KA, Cooney KA, Lange EM. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint men's health study. Prostate 2010;71:225-31.
18. Okobia MN, Zmuda JM, Ferrell RE, Patrick AL, Bunker CH. Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry. Prostate 2011;71:1054-63.
19. Al Olama AA, Kote-Jarai Z, Giles GG, Guy M, Morrison J, Severi G, et al. Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet 2009;41:1058-60.
20. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008;100:962-6. (Pubitemid 351957516)
21. Haiman CA, Patterson N, Freedman ML, Myers SR, Pike MC, Waliszewska A, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007;39:638-44. (Pubitemid 46676106)
22. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007;39:645-9. (Pubitemid 46676108)
23. Xu Z, Bensen JT, Smith GJ, Mohler JL, Taylor JA. GWAS SNP replication among African American and European American men in the North Carolina-Louisiana prostate cancer project (PCaP). Prostate 2010 Nov 17. [Epub ahead of print].
24. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, et al. A common variant associated with prostate cancer in European and African populations. Nat Genet 2006;38:652-8. (Pubitemid 43927306)
25. Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, et al. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 2007;67:2951-6. (Pubitemid 46724830)
26. Hooker S, Hernandez W, Chen H, Robbins C, Torres JB, Ahaghotu C, et al. Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans. Prostate 2010;70:270-5.
27. Gudmundsson J, Sulem P, Steinthorsdottir V, Bergthorsson JT, Thorleifsson G, Manolescu A, et al. Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes. Nat Genet 2007;39:977-83. (Pubitemid 47185170)
28. Sun J, Purcell L, Gao Z, Isaacs SD, Wiley KE, Hsu FC, et al. Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans. Prostate 2008;68:691-7. (Pubitemid 351632941)
29. Gudmundsson J, Sulem P, Rafnar T, Bergthorsson JT, Manolescu A, Gudbjartsson D, et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008;40:281-3. (Pubitemid 351311771)
30. Lu L, Sun J, Isaacs SD, Wiley KE, Smith S, Pruett K, et al. Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11. Cancer Epidemiol Biomarkers Prev 2009;18:2132-6.
31. Wang L, McDonnell SK, Slusser JP, Hebbring SJ, Cunningham JM, Jacobsen SJ, et al. Two common chromosome 8q24 variants are associated with increased risk for prostate cancer. Cancer Res 2007;67:2944-50. (Pubitemid 46724829)
32. Sun J, Lange EM, Isaacs SD, Liu W, Wiley KE, Lange L, et al. Chromosome 8q24 risk variants in hereditary and non-hereditary prostate cancer patients. Prostate 2008;68:489-97. (Pubitemid 351500209)
33. Beebe-Dimmer JL, Levin AM, Ray AM, Zuhlke KA, Machiela MJ, Halstead-Nussloch BA, et al. Chromosome 8q24 markers: risk of early-onset and familial prostate cancer. Int J Cancer 2008;122:2876-9. (Pubitemid 351631393)
34. Takata R, Akamatsu S, Kubo M, Takahashi A, Hosono N, Kawaguchi T, et al. Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. Nat Genet 2010;42:751-4.
35. Kim ST, Cheng Y, Hsu FC, Jin T, Kader AK, Zheng SL, et al. Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic variation. Prostate 2010;70:1729-38.
36. Liu H, Wang B, Han C. Meta-analysis of genome-wide association and replication association studies on prostate cancer. Prostate 2011;71:209-24.
37. Nieder AM, Taneja SS, Zeegers MPA, Ostrer H. Genetic counseling for prostate cancer risk. Clin Genet 2003;63:169-76. (Pubitemid 36949917)
38. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, et al. Replicating genotype-phenotype associations. Nature 2007;447:655-60. (Pubitemid 46889722)
39. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 2006;103:14068-73. (Pubitemid 44452981)
40. Wasserman NF, Aneas I, Nobrega MA. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res 2010;20:1191-7.
41. Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, et al. Evaluation of the 8q24 prostate cancer risk locus and MYC expression. Cancer Res 2009;69:5568-74.
42. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995;55:342-7.
43. Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, et al. Linkage disequilibrium in the human genome. Nature 2001;411:199-204. (Pubitemid 32455179)
44. Cheng I, Plummer SJ, Jorgenson E, Liu X, Rybicki BA, Casey G, et al. 8q24 and prostate cancer: association with advanced disease and meta-analysis. Eur J Hum Genet 2008;16:496-505. (Pubitemid 351420383)
45. Gallagher DJ, Vijai J, Cronin AM, Bhatia J, Vickers AJ, Gaudet MM, et al. Susceptibility loci associated with prostate cancer progression and mortality. Clin Cancer Res 2010;16:2819-32.
46. Wu G, Bohn S, Ryffel GU. The HNF1beta transcription factor has several domains involved in nephrogenesis and partially rescues Pax8/lim1-induced kidney malformations. Eur J Biochem 2004;271:3715-28. (Pubitemid 39233614)
47. Senkel S, Lucas B, Klein-Hitpass L, Ryffel GU. Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line. Biochim Biophys Acta 2005;1731:179-90.
48. Zheng SL, Stevens VL, Wiklund F, Isaacs SD, Sun J, Smith S, et al. Two independent prostate cancer risk-associated loci at 11q13. Cancer Epidemiol Biomarkers Prev 2009;18:1815-20.
49. Shukeir N, Arakelian A, Kadhim S, Garde S, Rabbani SA. Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer. Cancer Res 2003;63:2072-8. (Pubitemid 36546186)
50. Ahn J, Kibel AS, Park JY, Rebbeck TR, Rennert H, Stanford JL, et al. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clin Cancer Res 2011;17:1075-81.
51. Whitman EJ, Pomerantz M, Chen Y, Chamberlin MM, Furusato B, Gao C, et al. Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy. Cancer Epidemiol Biomarkers Prev 2010;19:1-8.
52. Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, et al. ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol 2001;21:6470-83. (Pubitemid 32927415)